Literature DB >> 10632606

BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain.

L A Mamounas1, C A Altar, M E Blue, D R Kaplan, L Tessarollo, W E Lyons.   

Abstract

Brain-derived neurotrophic factor (BDNF) has trophic effects on serotonergic (5-HT) neurons in the adult brain and can prevent the severe loss of cortical 5-HT axons caused by the neurotoxin p-chloroamphetamine (PCA). However, it has not been determined whether BDNF promotes the survival of 5-HT axons during PCA-insult or facilitates their regenerative sprouting after injury. We show here that BDNF fails to protect most 5-HT axons from PCA-induced degeneration. Instead, chronic BDNF infusions markedly stimulate the sprouting of both intact and PCA-lesioned 5-HT axons, leading to a hyperinnervation at the neocortical infusion site. BDNF treatment promoted the regrowth of 5-HT axons when initiated up to a month after PCA administration. The sprouted axons persisted in cortex for at least 5 weeks after terminating exogenous BDNF delivery. BDNF also encouraged the regrowth of the 5-HT plexus in the hippocampus, but only in those lamina where 5-HT axons normally ramify. In addition, intracortical BDNF infusions induced a sustained local activation of the TrkB receptor. The dose-response profiles for BDNF to stimulate 5-HT sprouting and Trk signaling were remarkably similar, suggesting a physiological link between the two events; both responses were maximal at intermediate doses of BDNF but declined at higher doses ("inverted-U-shaped" dose-response curves). Underlying the downregulation of the Trk signal with excessive BDNF was a decline in full-length TrkB protein, but not truncated TrkB protein or TrkB mRNA levels. Thus, BDNF-TrkB signaling does not protect 5-HT neurons from axonal injury, but has a fundamental role in promoting the structural plasticity of these neurons in the adult brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632606      PMCID: PMC6772430     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

Review 1.  Mechanisms of neurotrophic factor protection against calcium- and free radical-mediated excitotoxic injury: implications for treating neurodegenerative disorders.

Authors:  M P Mattson; B Cheng; V L Smith-Swintosky
Journal:  Exp Neurol       Date:  1993-11       Impact factor: 5.330

2.  Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo.

Authors:  S Cohen-Cory; S E Fraser
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

3.  Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group.

Authors:  D R Kaplan; K Matsumoto; E Lucarelli; C J Thiele
Journal:  Neuron       Date:  1993-08       Impact factor: 17.173

Review 4.  Intracellular signaling pathways activated by neurotrophic factors.

Authors:  R A Segal; M E Greenberg
Journal:  Annu Rev Neurosci       Date:  1996       Impact factor: 12.449

Review 5.  Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.

Authors:  M J Owens; C B Nemeroff
Journal:  Clin Chem       Date:  1994-02       Impact factor: 8.327

6.  Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3.

Authors:  J A Siuciak; C A Altar; S J Wiegand; R M Lindsay
Journal:  Brain Res       Date:  1994-01-07       Impact factor: 3.252

7.  Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives.

Authors:  L A Mamounas; C A Mullen; E O'Hearn; M E Molliver
Journal:  J Comp Neurol       Date:  1991-12-15       Impact factor: 3.215

8.  Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF.

Authors:  R J Cabelli; A Hohn; C J Shatz
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

9.  Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons.

Authors:  M P Mattson; M A Lovell; K Furukawa; W R Markesbery
Journal:  J Neurochem       Date:  1995-10       Impact factor: 5.372

Review 10.  Psychopharmacology of central serotonergic systems.

Authors:  H G Baumgarten; Z Grozdanovic
Journal:  Pharmacopsychiatry       Date:  1995-10       Impact factor: 5.788

View more
  81 in total

1.  Transplantation of olfactory mucosa minimizes axonal branching and promotes the recovery of vibrissae motor performance after facial nerve repair in rats.

Authors:  Orlando Guntinas-Lichius; Konstantin Wewetzer; Toma L Tomov; Natalie Azzolin; Shohreh Kazemi; Michael Streppel; Wolfrum F Neiss; Doychin N Angelov
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

2.  Memory impairment in transgenic Alzheimer mice requires cellular prion protein.

Authors:  David A Gimbel; Haakon B Nygaard; Erin E Coffey; Erik C Gunther; Juha Laurén; Zachary A Gimbel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

3.  BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.

Authors:  George S Alexopoulos; Charles E Glatt; Matthew J Hoptman; Dora Kanellopoulos; Christopher F Murphy; Robert E Kelly; Sarah S Morimoto; Kelvin O Lim; Faith M Gunning
Journal:  J Affect Disord       Date:  2010-03-25       Impact factor: 4.839

4.  Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines.

Authors:  Eija Koponen; Tomi Rantamäki; Vootele Voikar; Tommi Saarelainen; Ewen MacDonald; Eero Castrén
Journal:  Cell Mol Neurobiol       Date:  2005-09       Impact factor: 5.046

5.  Structural and functional modifications in glutamateric synapses following prolonged ethanol exposure.

Authors:  L Judson Chandler; Ezekiel Carpenter-Hyland; Adam W Hendricson; Regina E Maldve; Richard A Morrisett; Feng C Zhou; Youssef Sari; Richard Bell; Karen K Szumlinski
Journal:  Alcohol Clin Exp Res       Date:  2006-02       Impact factor: 3.455

6.  Imaging of serotonin mechanisms in epilepsy.

Authors:  Harry T Chugani; Diane C Chugani
Journal:  Epilepsy Curr       Date:  2005 Nov-Dec       Impact factor: 7.500

7.  Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor.

Authors:  Lisa M McFadden; Paula L Vieira-Brock; Glen R Hanson; Annette E Fleckenstein
Journal:  Int J Neuropsychopharmacol       Date:  2014-03-20       Impact factor: 5.176

8.  Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa.

Authors:  Stefan Ehrlich; Harriet Salbach-Andrae; Sarah Eckart; Julia V Merle; Roland Burghardt; Ernst Pfeiffer; Leonora Franke; Ralf Uebelhack; Ulrike Lehmkuhl; Rainer Hellweg
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

Review 9.  Neuropeptides in depression: role of VGF.

Authors:  Smita Thakker-Varia; Janet Alder
Journal:  Behav Brain Res       Date:  2008-10-15       Impact factor: 3.332

Review 10.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.